
The current EWL market cap is 35.96B. The company's latest EPS is USD 7.1009 and P/E is 9.77.
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 4.39B | 5.23B | 5.38B | 6B | 6.17B |
Operating Income | 897.6M | 1.57B | 1.71B | 1.51B | 1.36B |
Net Income | 823.4M | 1.5B | 1.52B | 1.4B | 4.17B |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 7.24B | 8.5B | 8.29B | 9.36B | 13.06B |
Total Liabilities | 2.66B | 2.67B | 2.49B | 2.64B | 2.99B |
Total Equity | 4.57B | 5.84B | 5.81B | 6.72B | 10.06B |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 1.05B | 1.73B | 1.22B | 895.8M | 542.3M |
Investing | -531.1M | -1.72B | 252.3M | 173.8M | 2.31B |
Financing | -486.9M | -356.3M | -1.58B | -711M | -983M |
Market Cap | 35.96B |
Price to Earnings Ratio | 9.77 |
Price to Sales Ratio | 6.61 |
Price to Cash Ratio | 13.4 |
Price to Book Ratio | 4.05 |
Dividend Yield | - |
Shares Outstanding | 587.9M |
Average Volume (1 week) | 4.26k |
Average Volume (1 Month) | 2.48k |
52 Week Change | -27.90% |
52 Week High | 87.58 |
52 Week Low | 54.01 |
Spread (Intraday) | 0.37 (0.6%) |
Company Name | Edwards Lifesciences Corp |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.edwards.com |
Industry | ortho,prosth,surg appl,suply (3842) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.